VA
MRNS
VR Adviser’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-1,770,705
| Closed | -$7.05M | – | 30 |
|
2022
Q4 | $7.05M | Sell |
1,770,705
-1,386,098
| -44% | -$5.52M | 1.19% | 21 |
|
2022
Q3 | $21M | Hold |
3,156,803
| – | – | 3.24% | 10 |
|
2022
Q2 | $15.3M | Hold |
3,156,803
| – | – | 3.01% | 11 |
|
2022
Q1 | $29.5M | Buy |
3,156,803
+276,707
| +10% | +$2.59M | 4.78% | 8 |
|
2021
Q4 | $34.2M | Buy |
2,880,096
+238,287
| +9% | +$2.83M | 4.68% | 8 |
|
2021
Q3 | $30.1M | Hold |
2,641,809
| – | – | 3.86% | 12 |
|
2021
Q2 | $47.4M | Hold |
2,641,809
| – | – | 5.75% | 5 |
|
2021
Q1 | $40.9M | Buy |
2,641,809
+52,868
| +2% | +$818K | 4.44% | 9 |
|
2020
Q4 | $31.6M | Buy |
2,588,941
+1,396,058
| +117% | +$17M | 4.64% | 8 |
|
2020
Q3 | $15.3M | Sell |
1,192,883
-4,533,657
| -79% | -$58.3M | 3% | 12 |
|
2020
Q2 | $14.5M | Sell |
5,726,540
-776,300
| -12% | -$1.97M | 3.48% | 9 |
|
2020
Q1 | $13.2M | Buy |
+6,502,840
| New | +$13.2M | 3.58% | 9 |
|